Literature DB >> 19026159

Modulation of major voltage- and ligand-gated ion channels in cultured neurons of the rat inferior colliculus by lidocaine.

Mu Yu1, Lin Chen.   

Abstract

AIM: The purpose of the present study was to explore how lidocaine as a therapeutic drug for tinnitus targets voltage- and ligand-gated ion channels and changes the excitability of central auditory neurons.
METHODS: Membrane currents mediated by major voltage- and ligand-gated channels were recorded from primary cultured neurons of the inferior colliculus (IC) in rats with whole-cell patch-clamp techniques in the presence and absence of lidocaine. The effects of lidocaine on the current-evoked firing of action potentials were also examined.
RESULTS: Lidocaine at 100 micromol/L significantly suppressed voltage-gated sodium currents, transient outward potassium currents, and the glycine-induced chloride currents to 87.66%+/-2.12%, 96.33%+/-0.35%, and 91.46%+/-2.69% of that of the control level, respectively. At 1 mmol/L, lidocaine further suppressed the 3 currents to 70.26%+/-4.69%, 62.80%+/-2.61%, and 89.11%+/-3.17% of that of the control level, respectively. However, lidocaine at concentrations lower than 1 mmol/L did not significantly affect GABA- or aspartate-induced currents. At a higher concentration (3 mmol/L), lidocaine slightly depressed the GABA-induced current to 87.70%+/-1.87% of that of the control level. Finally, lidocaine at 100 mumol/L was shown to significantly suppress the current-evoked firing of IC neurons to 58.62%+/-11.22% of that of the control level, indicating that lidocaine decreases neuronal excitability.
CONCLUSION: Although the action of lidocaine on the ion channels and receptors is complex and non-specific, it has an overall inhibitory effect on IC neurons at a clinically-relevant concentration, suggesting a central mechanism for lidocaine to suppress tinnitus.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19026159     DOI: 10.1111/j.1745-7254.2008.00893.x

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  3 in total

1.  PHARMACOLOGICAL TREATMENTS FOR TINNITUS: NEW AND OLD.

Authors:  R Salvi; E Lobarinas; W Sun
Journal:  Drugs Future       Date:  2009       Impact factor: 0.148

2.  Transdermal lidocaine as treatment for chronic subjective tinnitus: A pilot study.

Authors:  Daniel C O'Brien; Aaron D Robinson; Nancy Wang; Rodney Diaz
Journal:  Am J Otolaryngol       Date:  2019-03-18       Impact factor: 1.808

3.  Expressions of ion co-transporter genes in salicylate-induced tinnitus and treatment effects of spirulina.

Authors:  Juen-Haur Hwang; Yin-Ching Chan
Journal:  BMC Neurol       Date:  2016-09-02       Impact factor: 2.474

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.